Candesartan as an Adjunctive Treatment for Bipolar Depression

Stopped The reason the study was withdrawn was due to lack of funds. In addition, the PI is moving to a different institution and it would not be feasible to proceed with the study under these circumstances.

Conditions

• Bipolar Disorder Depression

Interventions

• DRUG: Candesartan
• DRUG: Placebo

Sponsor

The University of Texas Health Science Center, Houston